244 research outputs found
Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease
Parkinson’s disease (PD) is a devastating neurological movement disorder. Since its first discovery 200 years ago, genetic and environmental factors have been identified to play a role in PD development and progression. Although genetic studies have been the predominant driving force in PD research over the last few decades, currently only a small fraction of PD cases can be directly linked to monogenic mutations. The remaining cases have been attributed to other risk associated genes, environmental exposures and gene–environment interactions, making PD a multifactorial disorder with a complex etiology. However, enormous efforts from global research have yielded significant insights into pathogenic mechanisms and potential therapeutic targets for PD. This review will highlight mitochondrial dysfunction as a common pathway involved in both genetic mutations and environmental toxicants linked to PD
Analysis of time-profiles with in-beam PET monitoring in charged particle therapy
Background: Treatment verification with PET imaging in charged particle
therapy is conventionally done by comparing measurements of spatial
distributions with Monte Carlo (MC) predictions. However, decay curves can
provide additional independent information about the treatment and the
irradiated tissue. Most studies performed so far focus on long time intervals.
Here we investigate the reliability of MC predictions of space and time (decay
rate) profiles shortly after irradiation, and we show how the decay rates can
give an indication about the elements of which the phantom is made up.
Methods and Materials: Various phantoms were irradiated in clinical and
near-clinical conditions at the Cyclotron Centre of the Bronowice proton
therapy centre. PET data were acquired with a planar 16x16 cm PET system.
MC simulations of particle interactions and photon propagation in the phantoms
were performed using the FLUKA code. The analysis included a comparison between
experimental data and MC simulations of space and time profiles, as well as a
fitting procedure to obtain the various isotope contributions in the phantoms.
Results and conclusions: There was a good agreement between data and MC
predictions in 1-dimensional space and decay rate distributions. The fractions
of C, O and C that were obtained by fitting the decay
rates with multiple simple exponentials generally agreed well with the MC
expectations. We found a small excess of C in data compared to what was
predicted in MC, which was clear especially in the PE phantom.Comment: 9 pages, 5 figures, 1 table. Proceedings of the 20th International
Workshop on Radiation Imaging Detectors (iWorid2018), 24-28 June 2018,
Sundsvall, Swede
Analysis methods for in-beam PET images in proton therapy treatment verification: a comparison based on Monte Carlo simulations
Background and purpose: In-beam Positron Emission Tomography (PET) is one of
the modalities that can be used for in-vivo non-invasive treatment monitoring
in proton therapy. PET distributions obtained during various treatment sessions
can be compared in order to identify regions that have anatomical changes. The
purpose of this work is to test and compare different analysis methods in the
context of inter-fractional PET image comparison for proton treatment
verification.
Methods: For our study we used the FLUKA Monte Carlo code and artificially
generated CT scans to simulate in-beam PET distributions at different stages
during proton therapy treatment. We compared the Beam-Eye-View method, the
Most-Likely-Shift method, the Voxel-Based-Morphology method and the gamma
evaluation method to compare PET images at the start of treatment, and after a
few weeks of treatment. The results were compared to the CT scan.
Results and conclusions: Three-dimensional methods like VBM and gamma are
preferred above two-dimensional methods like MLS and BEV if much statistics is
available, since the these methods allow to identify the regions with anomalous
activity. The VBM approach has as disadvantage that a larger number of MC
simulations is needed. The gamma analysis has the disadvantage that no clinical
indication exist on tolerance criteria. In terms of calculation time, the BEV
and MLS method are preferred. We recommend to use the four methods together, in
order to best identify the location and cause of the activity changes.Comment: 9 pages, 5 figure
Online monitoring for proton therapy: A real-time procedure using a planar PET system
In this study a procedure for range verification in proton therapy by means of a planar in-beam PET system is presented. The procedure consists of two steps: the measurement of the β+-activity induced in the irradiated body by the proton beam and the comparison of these distributions with simulations. The experimental data taking was performed at the CNAO center in Pavia, Italy, irradiating plastic phantoms. For two different cases we demonstrate how a real-time feedback of the delivered treatment plan can be obtained with in-beam PET imaging
Monitoring Proton Therapy Through In-Beam PET: An Experimental Phantom Study
In this paper, we investigate the use of a positron emission tomography (PET) system to monitor the proton therapy. The monitoring procedure is based on the comparison between the β+ activity generated in the irradiated volume during the treatment, with the β+ activity distribution obtained with Monte Carlo (MC) simulation. The dedicated PET system is a dual head detection system; each head is composed of nine scintillating LYSO crystal matrices read out independently with a custom modularized acquisition system. Our experimental data were acquired at the Cyclotron Centre Bronowice, Institute Nuclear Physics in Kraków, Poland, and were simulated with the FLUKA MC code. Homogeneous and heterogeneous plastic phantoms were irradiated with monoenergetic 130 MeV protons. The capabilities of our PET system to distinguish different irradiated materials were investigated, and the proton pencil-beams were used as probes. Our focus was to analyze the activity width and the total activity event number in several cases. Irradiations were performed using either single pencil-beams one at a time, or two pencil-beams during the same data taking. The comparison of 1-D activity profile for experimental data and MC simulation were always in good agreement showing that, the treatment quality assessment in proton therapy can be based on β+ activity measurements
First full-beam PET acquisitions in proton therapy with a modular dual-head dedicated system
During particle therapy irradiation, positron emitters with half-lives ranging from 2 to 20 min are generated from nuclear processes. The half-lives are such that it is possible either to detect the positron signal in the treatment room using an in-beam positron emission tomography (PET) system, right after the irradiation, or to quickly transfer the patient to a close PET/CT scanner. Since the activity distribution is spatially correlated with the dose, it is possible to use PET imaging as an indirect method to assure the quality of the dose delivery. In this work, we present a new dedicated PET system able to operate in-beam. The PET apparatus consists in two 10 cm × 10 cm detector heads. Each detector is composed of four scintillating matrices of 23 × 23 LYSO crystals. The crystal size is 1.9 mm × 1.9 mm × 16 mm. Each scintillation matrix is read out independently with a modularized acquisition system. The distance between the two opposing detector heads was set to 20 cm. The system has very low dead time per detector area and a 3 ns coincidence window, which is capable to sustain high single count rates and to keep the random counts relatively low. This allows a new full-beam monitoring modality that includes data acquisition also while the beam is on. The PET system was tested during the irradiation at the CATANA (INFN, Catania, Italy) cyclotron-based proton therapy facility. Four acquisitions with different doses and dose rates were analysed. In all cases the random to total coincidences ratio was equal or less than 25%. For each measurement we estimated the accuracy and precision of the activity range on a set of voxel lines within an irradiated PMMA phantom. Results show that the inclusion of data acquired during the irradiation, referred to as beam-on data, improves both the precision and accuracy of the range measurement with respect to data acquired only after irradiation. Beam-on data alone are enough to give precisions better than 1 mm when at least 5 Gy are delivered
Full-beam performances of a PET detector with synchrotron therapeutic proton beams
Treatment quality assessment is a crucial feature for both present and nextgeneration ion therapy facilities. Several approaches are being explored, based on prompt radiation emission or on PET signals by β+;-decaying isotopes generated by beam interactions with the body. In-beam PET monitoring at synchrotron-based ion therapy facilities has already been performed, either based on inter-spill data only, to avoid the influence of the prompt radiation, or including both in-spill and inter-spill data. However, the PET images either suffer of poor statistics (inter-spill) or are more influenced by the background induced by prompt radiation (in-spill). Both those problems are expected to worsen for accelerators with improved duty cycle where the inter-spill interval is reduced to shorten the treatment time. With the aim of assessing the detector performance and developing techniques for background reduction, a test of an in-beam PET detector prototype was performed at the CNAO synchrotron-based ion therapy facility in full-beam acquisition modality. Data taken with proton beams impinging on PMMA phantoms showed the system acquisition capability and the resulting activity distribution, separately reconstructed for the in-spill and the inter-spill data. The coincidence time resolution for in-spill and inter-spill data shows a good agreement, with a slight deterioration during the spill. The data selection technique allows the identification and rejection of most of the background originated during the beam delivery. The activity range difference between two different proton beam energies (68 and 72 MeV) was measured and found to be in submillimeter agreement with the expected result. However, a slightly longer (2 mm) absolute profile length is obtained for in-spill data when compared to inter-spill data
Proton range monitoring with in-beam PET: Monte Carlo activity predictions and comparison with cyclotron data
n/
A new PET prototype for proton therapy: comparison of data and Monte Carlo simulations
Ion beam therapy is a valuable method for the treatment of deep-seated and radio-resistant tumors thanks to the favorable depth-dose distribution characterized by the Bragg peak. Hadrontherapy facilities take advantage of the specific ion range, resulting in a highly conformal dose in the target volume, while the dose in critical organs is reduced as compared to photon therapy. The necessity to monitor the delivery precision, i.e. the ion range, is unquestionable, thus different approaches have been investigated, such as the detection of prompt photons or annihilation photons of positron emitter nuclei created during the therapeutic treatment. Based on the measurement of the induced β+ activity, our group has developed various in-beam PET prototypes: the one under test is composed by two planar detector heads, each one consisting of four modules with a total active area of 10 × 10 cm2. A single detector module is made of a LYSO crystal matrix coupled to a position sensitive photomultiplier and is read-out by dedicated frontend electronics. A preliminary data taking was performed at the Italian National Centre for Oncological Hadron Therapy (CNAO, Pavia), using proton beams in the energy range of 93–112 MeV impinging on a plastic phantom. The measured activity profiles are presented and compared with the simulated ones based on the Monte Carlo FLUKA package
First tests for an online treatment monitoring system with in-beam PET for proton therapy
PET imaging is a non-invasive technique for particle range verification in
proton therapy. It is based on measuring the beta+ annihilations caused by
nuclear interactions of the protons in the patient. In this work we present
measurements for proton range verification in phantoms, performed at the CNAO
particle therapy treatment center in Pavia, Italy, with our 10 x 10 cm^2 planar
PET prototype DoPET. PMMA phantoms were irradiated with mono-energetic proton
beams and clinical treatment plans, and PET data were acquired during and
shortly after proton irradiation. We created 1-D profiles of the beta+ activity
along the proton beam-axis, and evaluated the difference between the proximal
rise and the distal fall-off position of the activity distribution. A good
agreement with FLUKA Monte Carlo predictions was obtained. We also assessed the
system response when the PMMA phantom contained an air cavity. The system was
able to detect these cavities quickly after irradiation.Comment: 11 pages, 6 figures, Proceedings for International Workshop on
Radiation Imaging Detectors, 201
- …